E. Havlik

发表

Increased137 Caesium Whole Body Radioactivity in High-Performance Athletes

P. Haber, H. Bergmann, E. Havlik, 1990, International journal of sports medicine.

Vasoactive intestinal peptide receptor scintigraphy.

W. Scheithauer, P. Valent, P. Angelberger, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Monitoring of the biodistribution and biokinetics of dysprosium-165 ferric hydroxide with a shadow-shield whole-body counter

P. Angelberger, H. Sinzinger, C. Pirich, 1997, European Journal of Nuclear Medicine.

Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma.

C. Herold, P. Angelberger, B. Niederle, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.

W. Schima, P. Angelberger, S. Li, 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Radiation synovectomy with (166)Ho-ferric hydroxide: a first experience.

H. Sinzinger, C. Pirich, A. Wanivenhaus, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

"MAURITIUS": tumour dose in patients with advanced carcinoma.

P. Angelberger, I. Virgolini, P. Smith-Jones, 1999, Italian journal of gastroenterology and hepatology.

Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.

W. Scheithauer, P. Angelberger, B. Niederle, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiation synovectomy using 165Dy ferric-hydroxide and oxidative DNA damage in patients with different types of arthritis.

H. Rüdiger, P. Angelberger, H. Sinzinger, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiation exposure from patients treated with 165Dy-ferric hydroxide

G. Karanikas, A. Hefner, H. Sinzinger, 2001, Nuclear medicine communications.

[Radiosynovectomy with dysprosium-165 iron hydroxide].

W. Graninger, P. Angelberger, H. Sinzinger, 1993, Acta medica Austriaca.

[Radiation doses deriving from patients treated with (166)Ho-ferric hydroxide].

H. Sinzinger, C. Pirich, E. Havlik, 2003, Nuklearmedizin. Nuclear medicine.

Radiation Exposure Deriving from Patients Treated with 165Dy-Ferric Hydroxide

G. Karanikas, H. Sinzinger, C. Pirich, 1999 .

Radiation Synovectomy With Dysprosium-165 ferric-hydroxide - Monitoring Of Biodistribution And Biokinetics With A Shadow Shield Whole-body Counter

P. Angelberger, H. Sinzinger, H. Aiginger, 1998 .

Prostaglandins as biochemical markers of radiation injury to the salivary glands after iodine-131 therapy?

H. Sinzinger, B. Peskar, E. Havlik, 1998, European Journal of Nuclear Medicine.

Radioactive contamination of contact lenses during radioiodine therapy.

G. Karanikas, G. Hanselmayer, G. Zettinig, 2000 .

Effects of oral cyclotropium bromide, hyoscine N-butylbromide and placebo on gastric emptying and antral motor activity in healthy man.

H. Bergmann, C. Schneider, G. Stacher, 1984, Gut.

Radioactive contamination of contact lenses during radioiodine therapy

G. Karanikas, G. Hanselmayer, G. Zettinig, 2000, Nuclear medicine communications.

New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.

P. Angelberger, B. Niederle, I. Virgolini, 2000, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Radiation Exposure around Patients after 201Tl-Myocardial Scintigraphy

I. Virgolini, A. Kurtaran, E. Havlik, 1997 .

Radiation doses deriving from patients undergoing 111In-DTPA-d-Phe-1-octreotide scintigraphy

H. Bergmann, B. Niederle, I. Virgolini, 1997, European Journal of Nuclear Medicine.

Radiation Exposure near of Patients after Administration of 99mTc-Sestamibi

B. Niederle, I. Virgolini, A. Kurtaran, 1997 .

Radiation Exposure around Patients after Administration of99mTc-DPD

A. Kurtaran, E. Havlik, J. Preitfellner, 1995 .

Passive incorporation of radioisotopes and airport security

Helmut Sinzinger, Paul Aiginger, Irmgard Neumann, 2007, Nuclear medicine communications.

Effects of oral pirenzepine on gastric emptying and antral motor activity in healthy man.

H. Bergmann, G. Stacher, E. Havlik, 1982, Scandinavian journal of gastroenterology. Supplement.

Triggering radiation alarm at security checks. Patients should be informed even after diagnostic nuclear medicine procedures.

B. Palumbo, I. Neumann, H. Sinzinger, 2009, Hellenic journal of nuclear medicine.

Radiation alarm at an airport after radioiodine therapy

I. Neumann, H. Sinzinger, P. Aiginger, 2005, Nuclear medicine communications.

Labial and palatal blood flow measurement before and after maxillary operations.

H. Bergmann, E. Havlik, R. Hoefer, 1976, Journal of maxillofacial surgery.